Search Results

There are 7244635 results for: content related to: Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis

  1. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis

    Veterinary Dermatology

    Volume 18, Issue 2, April 2007, Pages: 78–86, Thierry Olivry, Rosanna Marsella, Toshiroh Iwasaki, Ralf Mueller and The International Task Force On Canine Atopic Dermatitis

    Version of Record online : 7 MAR 2007, DOI: 10.1111/j.1365-3164.2007.00569.x

  2. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis

    Veterinary Dermatology

    Volume 23, Issue 6, December 2012, Pages: 515–e103, Jon D. Plant, Kinga Gortel, Marcel Kovalik, Nayak L. Polissar and Moni B. Neradilek

    Version of Record online : 9 NOV 2012, DOI: 10.1111/j.1365-3164.2012.01113.x

  3. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis

    Veterinary Dermatology

    Volume 23, Issue 1, February 2012, Pages: 4–e2, Tim J. Nuttall, Neil A. McEwan, Emmanuel Bensignor, Luisa Cornegliani, Christine Löwenstein and Christophe A. Rème

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1365-3164.2011.00992.x

  4. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial

    Veterinary Dermatology

    Volume 20, Issue 3, June 2009, Pages: 191–198, Tim Nuttall, Ralf Mueller, Emmanuel Bensignor, Maite Verde, Chiara Noli, Vanessa Schmidt and Christophe Rème

    Version of Record online : 3 APR 2009, DOI: 10.1111/j.1365-3164.2009.00756.x

  5. You have full text access to this OnlineOpen article
    A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

    Veterinary Dermatology

    Volume 26, Issue 1, February 2015, Pages: 23–e8, Peter R. Little, Vickie L. King, Kylie R. Davis, Sallie B. Cosgrove and Michael R. Stegemann

    Version of Record online : 12 DEC 2014, DOI: 10.1111/vde.12186

  6. The glucocorticoid sparing efficacy of PhytopicaTM in the management of canine atopic dermatitis

    Veterinary Dermatology

    Volume 21, Issue 1, February 2010, Pages: 97–105, Vanessa Schmidt, Neil McEwan, Andrea Volk, John Helps, Kevin Morrell and Tim Nuttall

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-3164.2009.00858.x

  7. You have full text access to this OnlineOpen article
    A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis

    Veterinary Dermatology

    Gina M. Michels, Deborah S. Ramsey, Kelly F. Walsh, Olivier M. Martinon, Sean P. Mahabir, Jacquelien D. Hoevers, Rodney R. Walters and Steven A. Dunham

    Version of Record online : 19 SEP 2016, DOI: 10.1111/vde.12376

  8. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial

    Veterinary Dermatology

    Volume 22, Issue 6, December 2011, Pages: 554–564, Pierre Cadot, Patrick Hensel, Emmanuel Bensignor, Céline Hadjaje, Geneviève Marignac, Luc Beco, Jacques Fontaine, Jean-François Jamet, Gabriela Georgescu, Karen Campbell, Andréa Cannon, Sarah C. Osborn, Linda Messinger, Michel Gogny-Goubert, Patrice Dubreuil, Alain Moussy and Olivier Hermine

    Version of Record online : 13 JUN 2011, DOI: 10.1111/j.1365-3164.2011.00990.x

  9. Prednisolone therapy for atopic dermatitis is less effective in dogs with lower pretreatment serum 25-hydroxyvitamin D concentrations

    Veterinary Dermatology

    Volume 23, Issue 2, April 2012, Pages: 125–e28, Marcel Kovalik, Keith L. Thoday, Jacqueline Berry, Adri H. M. van den Broek and Richard J. Mellanby

    Version of Record online : 5 DEC 2011, DOI: 10.1111/j.1365-3164.2011.01022.x

  10. Quality of life of dogs with skin diseases and their owners. Part 1: development and validation of a questionnaire

    Veterinary Dermatology

    Volume 22, Issue 4, August 2011, Pages: 335–343, Chiara Noli, Giovanni Minafò and Mario Galzerano

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1365-3164.2010.00954.x

  11. Assessment of the relationship between transepidermal water loss (TEWL) and severity of clinical signs (CADESI-03) in atopic dogs

    Veterinary Dermatology

    Volume 25, Issue 6, December 2014, Pages: 503–e83, Marcin Zając, Marcin P. Szczepanik, Piotr M. Wilkołek, Łukasz R. Adamek, Zbigniew J. H. Pomorski, Wiesław Sitkowski and Marcin G. Gołyński

    Version of Record online : 6 AUG 2014, DOI: 10.1111/vde.12150

  12. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs

    Veterinary Dermatology

    Volume 25, Issue 2, April 2014, Pages: 77–e25, Thierry Olivry, Manolis Saridomichelakis, Tim Nuttall, Emmanuel Bensignor, Craig E. Griffin and Peter B. Hill, for the International Committee on Allergic Diseases of Animals (ICADA)

    Version of Record online : 25 JAN 2014, DOI: 10.1111/vde.12107

  13. You have full text access to this OnlineOpen article
    A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis

    Veterinary Dermatology

    Volume 24, Issue 6, December 2013, Pages: 587–e142, Sallie B. Cosgrove, Jody A. Wren, Dawn M. Cleaver, Kelly F. Walsh, Stacey I. Follis, Vickie I. King, Jezaniah-Kira S. Tena and Michael R. Stegemann

    Version of Record online : 21 NOV 2013, DOI: 10.1111/vde.12088

  14. Author Index

    Clinical Pharmacology & Therapeutics

    Volume 99, Issue S1, February 2016, Pages: S108–S115,

    Version of Record online : 24 JAN 2016, DOI: 10.1002/cpt.311

  15. You have free access to this content
    A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008–2011 update

    Veterinary Dermatology

    Volume 24, Issue 1, February 2013, Pages: 97–e26, Thierry Olivry and Petra Bizikova

    Version of Record online : 19 JAN 2013, DOI: 10.1111/j.1365-3164.2012.01088.x

  16. Author Index

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue S1, February 2015, Pages: S105–S111,

    Version of Record online : 22 JAN 2015, DOI: 10.1002/cpt.57

  17. Quality of life of dogs with skin disease and of their owners. Part 2: administration of a questionnaire in various skin diseases and correlation to efficacy of therapy

    Veterinary Dermatology

    Volume 22, Issue 4, August 2011, Pages: 344–351, Chiara Noli, Silvia Colombo, Luisa Cornegliani, Giovanni Ghibaudo, Paola Persico, Antonella Vercelli and Mario Galzerano

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1365-3164.2011.00956.x

  18. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study

    Veterinary Dermatology

    Volume 24, Issue 6, December 2013, Pages: 576–e138, Kerstin Wildermuth, Sonja Zabel and Rod A. W. Rosychuk

    Version of Record online : 20 SEP 2013, DOI: 10.1111/vde.12067

  19. Malassezia dermatitis in dogs in Brazil: diagnosis, evaluation of clinical signs and molecular identification

    Veterinary Dermatology

    Volume 22, Issue 1, February 2011, Pages: 46–52, Mauro L.S. Machado, Laerte Ferreiro, Rafael R. Ferreira, Luis G. Corbellini, Manjula Deville, Madeleine Berthelemy and Jacques Guillot

    Version of Record online : 1 JUL 2010, DOI: 10.1111/j.1365-3164.2010.00909.x

  20. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study

    Veterinary Dermatology

    Volume 20, Issue 5-6, October/December 2009, Pages: 405–411, Didier Noël Carlotti, Marc Boulet, Joël Ducret, Gustavo Machicote, Pierre Jasmin, Christophe A. Rème and Maxime Albouy

    Version of Record online : 16 DEC 2009, DOI: 10.1111/j.1365-3164.2009.00848.x